JPRN-UMIN000009745招募中未知
High-sensitivity imaging of erlotinib in resected non-small-cell lung cancer - High-sensitivity imaging of erlotinib in resected non-small-cell lung cancer
Department of Internal Medicine Division of Medical Oncology & Respiratory Medicine Shimane University Faculty of Medicine0 个研究点目标入组 1 人开始时间: 2013年1月10日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 1
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Case with serious complications
研究者
相似试验
招募中
不适用
Imaging of [11C]erlotinib pharmacokinetics in non small cell lung cancer patients; an in vivo study with positron emission tomography10038666lung cancerNL-OMON32923Vrije Universiteit Medisch Centrum10
尚未招募
2 期
The Utility of PET/CT in Erlotinib treatment for Non-Small Cell canceron-small cell lung cancerJPRN-UMIN000002044Department of Respiratory Medicine, Allergy and Rheumatic Diseases, Osaka University Graduate School of Medicine20
已完成
不适用
Serum marker analysis of Erlotinib treatment in previously treated Non-small cell lung cancer (NSCLC) patients with and without Epidermal Growth Factor Receptor (EGFR) mutation (additional study of CJLSG0903/0904)on-small cell lung cancerJPRN-UMIN000005754Central Japan Lung Study Group (CJLSG)83
进行中（未招募）
不适用
MIMEB - Molecular Imaging with erlotinib and bevacizumab. A Phase II Clinical Trial to Evaluate the Accuracy of FDG-/FLT-PET and DCE-MRI for Early Prediction of Non-Progression in Patients with Advanced Non Squamous Cell Non Small Cell Lung Cancer (NSCLC) treated with Erlotinib and Bevacizumab and to Associate Imaging Findings with Molecular Markers - MIMEBEUCTR2009-012607-26-DEniversity of Cologne
已完成
不适用
[11C]Erlotinib tumor heterogeneity: an in vivo study using static whole body positron emission tomography in non-small cell lung cancer patients.lung cancerNL-OMON44987Vrije Universiteit Medisch Centrum30